Israel Active

Israeli twin sisters Merav and Michal Mor, both PhD graduates, were training for an Ironman triathlon and needed to measure their metabolic rate. No device existed, so they invented their own and founded Israeli startup Lumen (see previously).

Israel’s Ossio (see previously) has reported that orthopedic surgeons have implanted more than 10,000 Ossiofiber implants since their introduction in 2019. Ossio’s biofriendly Ossiofiber, and intelligent bone regeneration technology are designed to solve the shortcomings of conventional metal implants.

Israel’s Ibex Medical has expanded its partnership with France’s Medipath (see previously) to cover cancer analysis of multiple tissue types at more of Medipath’s 30 labs. Medipath provides pathology services to 250+ hospitals and clinics across France.

A new Tel Aviv University study showed that Pressure chamber therapy (Hyperbaric Oxygen Therapy - HBOT) significantly improved social skills in animal models of autism. It also reduced neuroinflammation, which is known to be associated with autism.

Before aggressive chemo, Tzvia had ovarian tissue frozen. 20 years later, doctors at Jerusalem’s Hadassah hospital defrosted and re-transplanted some of the tissue. It reversed her menopause and Tzvia has now given birth to a healthy baby girl – the longest ever time for a successful post-cancer transplant.

Scientists at Israel’s Assuta Ashdod Medical Center found why patients with a high-risk of coronary heart disease (e.g., some diabetics and smokers) have healthy arteries. Their endothelial progenitor cells have longer telomeres and greater function. It can help in developing preventative medicines.

Prof Mahmoud Saliman of Rambam Health Care Campus is the first in Israel to insert an ultrasound device through a vein (without anesthesia) to safely diagnose a patient suffering from atrial fibrillation (AFib). High-risk patients cannot have anesthesia or blood thinners.

More details about Israel’s IdentifAI Genetics (see previously) and its Hoobari blood test invented by Tel Aviv University’s Professor Noam Shomron. The test separates the DNA of a 10-week fetus from that of its mother and then checks it for mutations. Much safer than amniocentesis.

HAMA (see previously) is among the pioneering organizations in Animal Assisted Intervention in Therapy and Education in Israel. Many of the animals are rescued from abuse and neglect, and have in turn enriched humans suffering from trauma, deep loss, and abandonment.

The Ivory Dentin Graft™ dentin graft material from Israel’s Ivory Graft has just received the European CE Mark for use in the repair or augmentation of bone defects. Its similarity to bone makes it an ideal grafting material, e.g., in dental procedures.